glp-1 news 2025 november Agonists Weight Loss Drugs Market Report, 2025-2030 Boston, USA. 16th Nov, 2025.

The result is fewer side effects than the other GLP-1 agonists, along with more weight loss and better insulin control, Skelley notes

Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JF, Nauck MA, et al

Patients will begin to notice more substantial changes in weight at around 5-8 weeks, especially patients who have made lifestyle changes alongside GLP-1 treatments

In addition, T2DM is associated with an increased risk of stroke and mortality after stroke (79)

GLP-1 is a naturally occurring hormone that helps regulate appetite and digestion

Drug interactions are possible with prescription pain medications and other medications